Parallax Volatility Advisers, L.P. Cytokinetics Inc Transaction History
Parallax Volatility Advisers, L.P.
- $42.9 Billion
- Q2 2025
A detailed history of Parallax Volatility Advisers, L.P. transactions in Cytokinetics Inc stock. As of the latest transaction made, Parallax Volatility Advisers, L.P. holds 4,889 shares of CYTK stock, worth $291,482. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,889
Previous 2,000
144.45%
Holding current value
$291,482
Previous $80,000
101.25%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding CYTK
# of Institutions
388Shares Held
129MCall Options Held
3.62MPut Options Held
1.14M-
T. Rowe Price Investment Management, Inc. Baltimore, MD17.6MShares$1.05 Billion0.37% of portfolio
-
Black Rock Inc. New York, NY14.7MShares$875 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$714 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA7.83MShares$467 Million0.05% of portfolio
-
State Street Corp Boston, MA6.37MShares$380 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $5.61B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...